设为首页 电子邮箱 联系我们

本刊最新招聘信息请见“通知公告”!  本刊投稿系统试运行中,欢迎投稿!如投稿有问题,可直接将稿件发送至zgyy8888@163.com

 

主管单位:中华人民共和国   

国家卫生健康委员会

主办单位:
总编辑:
杨秋

编辑部主任:吴翔宇

邮发代号:80-528
定价:28.00元
全年:336.00元
Email:zgyy8888@163.com
电话(传真):010-64428528;
010-64456116(总编室)

                  

2021 年第 8 期 第 16 卷

经皮肝穿刺胆道引流术和胆道支架置入术治疗恶性胆道梗阻的术后并发症及其危险因素研究进展

Research progress on complications of percutaneous transhepatic cholangial drainage and percutaneous transhepatic biliary stenting in the treatment of malignant biliary obstruction and its risk factors

作者:贾楠刘兆玉

英文作者:Jia Nan Liu Zhaoyu

单位:中国医科大学附属盛京医院放射科,沈阳110004

英文单位:Department of Radiology Shengjing Hospital of China Medical University Shenyang 110004 China

关键词:恶性胆道梗阻;经皮肝穿刺胆道引流术;胆道支架置入术;并发症;危险因素

英文关键词:Malignantbiliaryobstruction;Percutaneoustranshepaticcholangialdrainage;Percutaneoustranshepaticbiliarystenting;Complications;Riskfactors

  • 摘要:
  • 恶性胆道梗阻是由恶性肿瘤导致的胆道狭窄或闭塞。随着介入技术及医学材料的发展,经皮肝穿刺胆道引流术(PTCD)和胆道支架置入术(PTBS)已成为解除胆道梗阻的主要姑息性治疗方法。胆道感染、急性胰腺炎、胆道出血、支架再狭窄及胆心反射等并发症均影响患者的生活质量及生存期。探究PTCD/PTBS术后相关并发症及其危险因素,对改善恶性胆道梗阻患者预后具有重要的临床意义。

  • Malignant biliary obstruction is caused by biliary stenosis or obstruction due to malignant tumor. With the development of interventional techniques and medical materials, percutaneous transhepatic cholangial drainage (PTCD) and percutaneous transhepatic biliary stenting (PTBS) have already become the main palliative therapy to relieve biliary obstruction. The complications, including biliary tract infection, acute pancreatitis, biliary tract hemobilia, biliary stent restenosis and biliary-cardiac reflex and so on, seriously affect the quality of life and survival time of the patients. Understanding the complications and risk factors of PTCD/PTBS has important clinical significance for improving the prognosis of patients with malignant biliary obstruction.

copyright
地址:北京市朝阳区安贞路2号首都医科大学附属北京安贞医院北楼二层
电话:010-64456116 传真:010-64428528 邮编:100029 Email: zgyy8888@163.com
网址: 京ICP备2020043099号-3

当您在使用本网站投稿遇到困难时,请直接将稿件投送到编辑部邮箱zgyy8888@163.com。







安卓


苹果

关闭
Baidu
map